Publication | Closed Access

Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization

Induced Pluripotent Stem CellGrowth FactorMedicineStem Cell MobilizationStem Cell ResearchStem-cell TherapyPatient-adapted UseCell TransplantationRadiation OncologyStem CellsCell BiologyTumor MicroenvironmentHealth Sciences